Gut Microbiota is Altered in Patients with Alzheimer's Disease.

  title={Gut Microbiota is Altered in Patients with Alzheimer's Disease.},
  author={Zhen-Qian Zhuang and Lin-Lin Shen and Wei-Wei Li and Xue Fu and Fan Zeng and Li Gui and Yang L{\"u} and Min Cai and Chi Zhu and Yin-Ling Tan and Peng Zheng and Huiyun Li and Jie Zhu and Huadong Zhou and Xian-Le Bu and Yanjiang Wang},
  journal={Journal of Alzheimer's disease : JAD},
  volume={63 4},
Previous studies suggest that gut microbiota is associated with neuropsychiatric disorders, such as Parkinson's disease, amyotrophic lateral sclerosis, and depression. However, whether the composition and diversity of gut microbiota is altered in patients with Alzheimer's disease (AD) remains largely unknown. In the present study, we collected fecal samples from 43 AD patients and 43 age- and gender-matched cognitively normal controls. 16S ribosomal RNA sequencing technique was used to analyze… 

Figures and Tables from this paper

Alteration of Gut Microbiota in Alzheimer's Disease and Their Relation to the Cognitive Impairment.

A higher abundance of Prevotella species and lactic acid bacteria was correlated with cognition and a significant relationship between AD and gut microbiota dysbiosis was highlighted.

Gut Microbiota Changes and Their Correlation with Cognitive and Neuropsychiatric Symptoms in Alzheimer's Disease.

AD patients have gut microbiota alterations related to cognition, and differential taxa between AD patients with and without NPS associated differently with NPS domains, which helps further understand the pathogenesis of AD and explore potential therapeutic targets.

Structural and Functional Dysbiosis of Fecal Microbiota in Chinese Patients With Alzheimer's Disease

The structural and functional dysbiosis of fecal microbiota in AD patients is established and the potential for use of gut bacteria for the early, non-invasive diagnosis of AD, personalized treatment, and the development of tailor-made probiotics designed for Chinese AD patients are suggested.

Analysis of Salivary Microbiome in Patients with Alzheimer's Disease.

It is discovered that the composition of salivary microbiome was altered in AD, providing further support for the role of the oral microbiome in AD development.

Altered Gut Microbiota and Its Clinical Relevance in Mild Cognitive Impairment and Alzheimer’s Disease: Shanghai Aging Study and Shanghai Memory Study

The hypothesis that intestinal microorganisms change in MCI and AD is supported, and the alteration in specific taxa correlated closely with clinical manifestations, indicating the potential role in AD pathogenesis.

The Oral and Fecal Microbiota in a Canadian Cohort of Alzheimer's Disease.

The gut microbiota of AD patients was not overtly different from controls, although it displayed lower diversity, an overall marker of microbiota health, and the oral microbiota did display marked differences, although taxonomic differences were sparse.

Fecal Fungal Dysbiosis in Chinese Patients With Alzheimer’s Disease

This study is the first to demonstrate fecal fungal dysbiosis in stable AD patients at a deeper level, and to identify the key differential fungi involved in regulating host systemic immunity.

The Microbiota-Gut-Brain Axis in Alzheimer's Disease: A Review of Taxonomic Alterations and Potential Avenues for Interventions.

The gut microbiome may provide insight into ad pathology and be a novel target for intervention, potential therapeutics include probiotics and dietary intervention.

Altered Gut Microbiota in Adults with Subjective Cognitive Decline: The SILCODE Study.

The composition of gut microbiota is altered in individuals with SCD, and novel insights into the pathophysiological mechanism of AD are provided.

Stratification of the Gut Microbiota Composition Landscape Across the Alzheimer’s Disease Continuum in a Turkish Cohort

It is demonstrated that while Prevotella and Bacteroides clusters are the consensus partitions the newly developed probabilistic methods can provide fine scale resolution in partitioning the AD gut microbiome landscape.



Gut microbiome alterations in Alzheimer’s disease

The gut microbiome of AD participants has decreased microbial diversity and is compositionally distinct from control age- and sex-matched individuals, which adds AD to the growing list of diseases associated with gut microbial alterations, as well as suggest that gut bacterial communities may be a target for therapeutic intervention.

Altered Gut Microbiota in a Mouse Model of Alzheimer's Disease.

It is shown that AD pathology might not only affect brain function directly, but also exacerbate cognitive deficits through reducing the level of SCFAs via alterations of gut microbiota induced by intestinal amyloid deposition, suggesting a novel route for therapeutic intervention in AD.

Alzheimer’s disease and gut microbiota

All the results suggest that AD may begin in the gut, and is closely related to the imbalance of gut microbiota, and will probably become a new treatment for AD.

Gut microbiota: Implications in Parkinson's disease

Antibiotic-induced perturbations in gut microbial diversity influences neuro-inflammation and amyloidosis in a murine model of Alzheimer’s disease

It is shown that prolonged shifts in gut microbial composition and diversity induced by long-term broad-spectrum combinatorial antibiotic treatment regime decreases Aβ plaque deposition and attenuated plaque-localised glial reactivity in these mice and significantly altered microglial morphology.

From gut dysbiosis to altered brain function and mental illness: mechanisms and pathways

Roles of gut microbiome in shaping brain development and neurological function, and the mechanisms by which it can contribute to mental illness are examined; how the insight provided by this new and exciting field of research can inform care and provide a basis for the design of novel, microbiota-targeted, therapies is discussed.

Human gut microbiota: the links with dementia development

New researches indicate that gastrointestinal tract microbiota are directly linked to dementia pathogenesis through triggering metabolic diseases and low-grade inflammation progress, and a novel strategy is proposed for the management of these disorders and as an adjuvant for psychiatric treatment of dementia.

Gut microbiome remodeling induces depressive-like behaviors through a pathway mediated by the host’s metabolism

It is demonstrated that dysbiosis of the gut microbiome may have a causal role in the development of depressive-like behaviors, in a pathway that is mediated through the host’s metabolism.

Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour

The emerging concept of a microbiota–gut–brain axis suggests that modulation of the gut microbiota may be a tractable strategy for developing novel therapeutics for complex CNS disorders.